To view this email as a web page, click here.

 
 
CGRP Inhibitor and OnabotulinumtoxinA Therapy Boosts Relief in Severe Chronic Migraine
For years, study participants had been suffering with migraine symptoms and had failed at least three to five therapies before enrolling in the trial.
Image ©Andrea Danti/Shutterstock.com
Read more
 
Novel Technologies in Neurology
As home-monitoring devices become more available, accessible, and useful, they are increasingly helpful in neurological decision-making.
Image ©blackzheep/Shutterstock.com
Read more
ADVERTISEMENT

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.